%A LENG ZhengWei；Yang Gang；Li Yong；Shi-Gang %T LY294002 decreases the proliferation of cancer stem cell-enriched spheroid cells from human hepatocellular carcinoma via inhibiting of PI3K-Akt signaling pathway %0 Journal Article %D 2015 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2015.04.001 %P 241-244 %V 42 %N 4 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9634.shtml} %8 2015-04-08 %X ObjectiveTo investigate the impact of LY294002 on the proliferation of cancer stem cellenriched spheroid cells from human hepatocellular carcinoma via regulating phosphatidylinositol3kinaseprotein kinase B (PI3KAkt) signaling pathway.MethodsThe cancer stem cellenriched spheroid cells were generated by culturing HepG2 cells in serumfree medium. LY294002 (10, 20, 30 μmol/L), an inhibitor of PI3KAkt signaling pathway, was used in the experimental groups, without used in the control group. The impact of LY294002 on the spheroid cells proliferation was confirmed by cell counting kit (CCK8 kit). The expression of Akt was tested by Western blotting. The expression of PI3KAkt signaling pathway downstream genes such as decoy receptor 3 (DcR3), mammalian target of rapamycin (mTOR), Bcell lymphoma (Bcl)2 and Cyclin D1 were tested by realtime PCR.Results30 μmol/L LY294002 could inhibit the proliferation of spheroid cells, and significant difference in the absorbance (A value) was observed between the experimental group and control group［(0.14±0.03) vs (0.56±0.01), t=-8.915, P=0.000］. The expression level of phosphorylated Akt protein increased［(0.57±0.08) vs (0.16±0.42), t=6.027, P=0.026］. The mRNA of DcR3［(0.38±0.08) vs 1, t=13.060, P=0.006］, mTOR［(0.37±0.04) vs 1, t=30.363, P=0.001］, Bcl2［(0.26±0.04) vs 1, t=33.554, P=0.001］ and Cyclin D1［(0.10±0.02) vs 1, t=63.528, P=0.000］ decreased.ConclusionLY294002 could inhibit the proliferation of cancer stem cellenriched spheroid cells from human hepatocellular carcinoma via inhibiting PI3KAkt signaling pathway.